Michael T. Massaro

Michael Massaro practices at Sacramento Midtown Endoscopy Center in Sacramento, California.

Michael Massaro's NPI, 1558741447, was assigned on June 4, 2015. Michael Massaro graduated from University of Tennessee Health Science Center College of Medicine - Memphis in 2015. Michael Massaro holds California license A172725.

Michael Massaro's primary practice is Sacramento Midtown Endoscopy Center, at 3941 J Street, Suite 460, Sacramento, CA 95819. The practice phone is (916) 733-6940.

Michael Massaro's primary practice is Sacramento Midtown Endoscopy Center in Sacramento, California. Michael Massaro is also affiliated with Dignity Health - Mercy General Hospital. The medical group on file is Mercy Medical Group. Dmand AI also links Michael Massaro to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Michael Massaro practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Michael Massaro's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Michael Massaro is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Michael Massaro's licenses on file in 3 states: California, Alabama and North Carolina.

Dmand AI lists acid reflux, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, esophagus, stomach, or upper small intestine surgery, fatty liver, gastroenteritis and gastrointestinal bleeding among the conditions Michael Massaro treats.

CMS data shows 722 Medicare services from Michael Massaro across 14 procedure codes in 2024, for 443 Medicare patients. Medicare paid $85,546 for them.

CMS counts 443 Medicare patients who saw Michael Massaro in 2024. The largest group is 65 to 74, with 218 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 34% are also on Medicaid. Their average risk score is 1.38, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Michael Massaro's median patient age at 63, with 55% women.

In 2024, Michael Massaro wrote 994 Medicare Part D claims for 403 patients. 83% of them were for generic drugs. CMS names the drug for 830 of them, across 13 drugs with 11 or more claims each, at $70,238 in total drug cost. In 2023, CMS named 775 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Michael Massaro for performance year 2024, reported through an alternative payment model (APM). Michael Massaro accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Michael Massaro as offering telehealth. CMS counts 166 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Michael Massaro, more than 87% of the clinicians it reports for that procedure.

Dmand AI links 3 papers to Michael Massaro in 2020. 2020 was the busiest year, with 2. Michael Massaro's most frequent co-authors are Katherine Rachel Birchard, MD, Evan S. Dellon, MD, MPH and Caleb J. Doyle-Burr.

CMS Open Payments shows 111 general payments to Michael Massaro from 13 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 97% of the total. Sanofi and Genzyme US Companies paid the most, $756.

Michael Massaro graduated from University of Tennessee Health Science Center College of Medicine - Memphis in 2015.

Michael Massaro is in network with 14 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.